Résumé

Sickle cell disease is a common pathology in Senegal, characterized by acute pain during vaso-oclusive crises (VOCs), which represent a major reason for consultation and hospitalization. This study aims to evaluate pain management in children with major sickle cell syndromes (MDS). This retrospective study was carried out in patients followed for SDM at the outpatient care unit for children and adolescents with sickle cell disease (USAD) of the Centre Hospitalier National d'Enfants Albert Royer (CHNEAR) in Dakar, between January 2 and March 31, 2023. We included all children under 15 years of age who were consulted in the USAD emergency department and who had received pain management. We analyzed 100 SDM records, 57 of which were girls, resulting in a sex ratio of 0.75. The most represented age group was 6 to 10 years old (45% of patients). Pain was the most common mode of revelation (84% of children). In 2023, 11 children had more than 3 hospitalizations for pain, mainly localized to the limbs (70%). Pain assessment was performed in 37% of children at the consultation. The combination of level I (paracetamol) and level II (Tramadol) analgesics was used in 39 children. The time to administration of the first dose was estimated at 15 minutes in 67% of patients, while the post-analgesic evaluation was only performed after 5 hours for 41 children.

Mot-clés :

Pain, Child, Sickle Cell Disease, Senegal